Insulin Cap for Medicare Patients Signals Hope
Medicare will gain the power to
start negotiating costs for pharmaceuticals and out-of-pocket prescription
costs will be limited to $2,000 starting in 2025. In January the cost of
insulin for patients on Medicare will be capped at $35 a month.
No comments:
Post a Comment